Charles River Laboratories Operating Income 2010-2024 | CRL

Charles River Laboratories annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Charles River Laboratories operating income for the quarter ending June 30, 2024 was $0.152B, a 8.06% decline year-over-year.
  • Charles River Laboratories operating income for the twelve months ending June 30, 2024 was $0.562B, a 13.21% decline year-over-year.
  • Charles River Laboratories annual operating income for 2023 was $0.617B, a 5.18% decline from 2022.
  • Charles River Laboratories annual operating income for 2022 was $0.651B, a 10.36% increase from 2021.
  • Charles River Laboratories annual operating income for 2021 was $0.59B, a 36.31% increase from 2020.
Charles River Laboratories Annual Operating Income
(Millions of US $)
2023 $617
2022 $651
2021 $590
2020 $433
2019 $351
2018 $331
2017 $288
2016 $238
2015 $206
2014 $178
2013 $151
2012 $166
2011 $174
2010 $-299
2009 $170
Charles River Laboratories Quarterly Operating Income
(Millions of US $)
2024-06-30 $152
2024-03-31 $126
2023-12-31 $133
2023-09-30 $152
2023-06-30 $165
2023-03-31 $168
2022-12-31 $164
2022-09-30 $151
2022-06-30 $187
2022-03-31 $149
2021-12-31 $173
2021-09-30 $156
2021-06-30 $138
2021-03-31 $124
2020-12-31 $129
2020-09-30 $133
2020-06-30 $77
2020-03-31 $94
2019-12-31 $109
2019-09-30 $93
2019-06-30 $80
2019-03-31 $70
2018-12-31 $102
2018-09-30 $84
2018-06-30 $77
2018-03-31 $68
2017-12-31 $63
2017-09-30 $74
2017-06-30 $82
2017-03-31 $70
2016-12-31 $69
2016-09-30 $59
2016-06-30 $58
2016-03-31 $51
2015-12-31 $52
2015-09-30 $55
2015-06-30 $56
2015-03-31 $43
2014-12-31 $41
2014-09-30 $46
2014-06-30 $51
2014-03-31 $40
2013-12-31 $25
2013-09-30 $41
2013-06-30 $43
2013-03-31 $43
2012-12-31 $35
2012-09-30 $38
2012-06-30 $49
2012-03-31 $44
2011-12-31 $42
2011-09-30 $37
2011-06-30 $53
2011-03-31 $42
2010-12-31 $-365
2010-09-30 $6
2010-06-30 $30
2010-03-31 $30
2009-12-31 $35
2009-09-30 $44
2009-06-30 $51
2009-03-31 $40
Sector Industry Market Cap Revenue
Medical Medical Services $9.742B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00